Sukhi Jagpal

CIK 1554591 · Chief Financial Officer · last filed 2026-06-09

Sukhi Jagpal is a Chief Financial Officer who has filed 19 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for STRO, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$628.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $34.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$34.9K

Companies

4

Total Filings

19

Lifetime Open-Market Net

-$628.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STRO Director $28.80 $0 4 2026-06-09
Sierra Oncology, Inc. (SRRA) Delisted Chief Financial Officer $54.99 $0 10 2022-07-01
Sierra Oncology, Inc. (DNAI) Delisted Chief Financial Officer $0 2 2016-10-04
QLTI Chief Financial Officer 1,300 $26.82 $34.9K -$628.2K 3 2013-07-17

Recent Filings

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-09 STRO Grant (A) $0 EDGAR
2025-12-29 STRO Grant (A) $0 EDGAR
2025-06-10 STRO Grant (A) $0 EDGAR
2024-08-12 STRO Grant (A) $0 EDGAR
2022-07-01 Sierra Oncology, Inc. (SRRA) Delisted Disp (D) $0 EDGAR
2022-06-17 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
2022-03-14 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
2022-01-28 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
2021-03-17 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
2020-08-12 Sierra Oncology, Inc. (SRRA) Delisted Grant (A) $0 EDGAR
Showing 110 of 19
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.